Emily Jane Woo
- Epidemiology top 10%
- Infectious Diseases top 5%
- Molecular Biology
- Surgery top 10%
- Health top 2%
- Co-authors
- Robert BallM. Miles BraunTaxiarchis BotsisPedro L. MoroDale R. BurwenMichael NguyenMaria CanoRobert Peter Aaronson
- Topics
- SARS-CoV-2 and COVID-19 Research (12 papers)Influenza Virus Research Studies (12 papers)Peripheral Neuropathies and Disorders (10 papers)
- Cited by
- ToxicologyHealthInfectious Diseases
- Partner nations
- United StatesNorwayHong Kong
In The Last Decade
Emily Jane Woo
65 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 136
- Epidemiology 448
- Infectious Diseases 363
- Molecular Biology 361
- Surgery 305
- Health 257
Countries citing papers authored by Emily Jane Woo
This map shows the geographic impact of Emily Jane Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Jane Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Jane Woo more than expected).
Fields of papers citing papers by Emily Jane Woo
This network shows the impact of papers produced by Emily Jane Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Jane Woo. The network helps show where Emily Jane Woo may publish in the future.
Co-authorship network of co-authors of Emily Jane Woo
This figure shows the co-authorship network connecting the top 25 collaborators of Emily Jane Woo. A scholar is included among the top collaborators of Emily Jane Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Jane Woo. Emily Jane Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 41 | |
| 3 | 2 | |
| 4 | 17 | |
| 5 | 13 | |
| 6 | 28 | |
| 7 | 21 | |
| 8 | 22 | |
| 9 | 16 | |
| 10 | 11 | |
| 11 | 9 | |
| 12 | 16 | |
| 13 | 8 | |
| 14 | 84 | |
| 15 | 91 | |
| 16 | 13 | |
| 17 | 18 | |
| 18 | 41 | |
| 19 | 65 | |
| 20 | 78 |
About Emily Jane Woo
Emily Jane Woo is a scholar working on Toxicology, Microbiology and Health, having authored 66 papers that have together received 1.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), Influenza Virus Research Studies (12 papers) and Peripheral Neuropathies and Disorders (10 papers). The work is most often cited by research in Toxicology (217 citations), Health (257 citations) and Infectious Diseases (363 citations). Emily Jane Woo has collaborated with scholars based in United States, Norway and Hong Kong. Frequent co-authors include Robert Ball, M. Miles Braun, Taxiarchis Botsis, Pedro L. Moro, Dale R. Burwen, Michael Nguyen, Maria Cano, Robert Peter Aaronson, Penina Haber and Scott K. Winiecki. Their work appears in journals such as JAMA, Journal of Biological Chemistry and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.